Company
Aardvark Therapeutics, Inc. (AARD)
Standardized SEC financial data for Aardvark Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001774857 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-54.0%
Free cash flow
-$54.3M
Current ratio
10.61×
EPS (diluted)
$-2.93
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2024 | FY2025 |
|---|---|---|
| Revenue | — | $0 |
| R&D expense | $17.4M | $48.9M |
| SG&A expense | $5.3M | $13.8M |
| Operating income | -$22.8M |
Balance sheet
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $9.7M | $61.6M | $110.0M |
| Total current assets | — | $74.1M | $111.9M |
| Total assets | — | $77.5M |
Cash flow
| USD | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | -$18.1M | -$54.2M |
| Capital expenditures | $109K | $95K |
| Free cash flow | -$18.2M | -$54.3M |
| Investing cash flow | -$12.0M |
Get AARD data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/AARD/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/AARD/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"